Interstitial fluid analysis for assessment of organ function.
Evaluation methods are required for non-heart-beating donor (NHBD) kidneys to ensure the success of transplantation. In this study, the microdialysis technique was employed for the ex-vivo assessment of hypothermically preserved NHBD kidney function. Microdialysis probes were placed in the renal cortex of 2 h warm ischaemic porcine kidneys to monitor interstitial pyruvate dynamics during hypothermic machine perfusion with perfusate containing 29.4 mM fructose-1,6-diphosphate (FDP). The presence of exogenous FDP in the perfusate induced no changes in the renal flow rate and vascular resistance, renal artery effluent biochemistry, or pyruvate concentration relative to untreated control kidneys. Significant increases in pyruvate production (P < 0.05), however, were observed after 12 h of perfusion in the interstitial fluid of FDP-treated kidneys relative to control kidneys. After 24 h of perfusion, interstitial fluid concentrations of pyruvate were 149.1 +/- 58.4 vs. 55.6 +/- 17.9 micro M (P < 0.05) in the FDP and control group, respectively. The microdialysis probe collected the interstitial fluid directly from the cellular sites of metabolic and synthetic activity, where perfusate dilution was minimal. Consequently, the biochemical changes induced by the organ metabolic activity were detected only at the interstitial level, in the microdialysates. Interstitial fluid pyruvate may be a good indicator of kidney function. The addition of FDP to the perfusion solution during ischaemic kidney preservation resulted in enhanced pyruvate production in the extracellular space, indirectly reflecting an increase in anaerobic ATP production. The pyruvate will be transformed during organ reperfusion into acetyl Co-A enzyme allowing an immediate start of aerobic metabolism. This in turn can increase the amount of ATP available to the cells and may help prevent reperfusion injury upon transplantation.
Baicu
Simona C
SC
Organ Recovery Systems, Charleston, SC 29403, USA. sbaicu@organ-recovery.com
Simmons
Patricia M
PM
Campbell
Lia H
LH
Taylor
Michael J
MJ
Brockbank
Kelvin G M
KG
D000818:Animals; D045604:Extracellular Fluid / Q000502:physiology*; D006597:Fructose-Bisphosphatase / Q000378:metabolism / Q000494:pharmacology*; D018698:Glutamic Acid / Q000032:analysis; D006019:Glycolysis; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation / Q000502:physiology*; D017551:Microdialysis; D019188:Organ Preservation Solutions / Q000737:chemistry*; D012077:Renal Artery / Q000737:chemistry; D013552:Swine
D019188:Organ Preservation Solutions; D018698:Glutamic Acid; D006597:Fructose-Bisphosphatase